ArticleSkeletal radiology2019
B-cell peripheral neurolymphomatosis: MRI and
Article in Skeletal radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.
- Imaging of non-neurogenic peripheral nerve malignancy-a case series and systematic review.Skeletal radiology · 2021Pooled it
- FDG PET characteristics of intraneural perineurioma: patient series.Journal of neurosurgery. Case lessons · 2026Article
- Article
- Temporal evolution of tumefactive neurolymphomatosis with serial MRI and positron emission tomography: illustrative case.Journal of neurosurgery. Case lessons · 2026Article
- Neurolymphomatosis: A Comprehensive Review of Clinical and Imaging Features.Radiology. Imaging cancer · 2026Review
- Tumor Inflammation-associated Neurotoxicity Following CD19-targeted Chimeric Antigen Receptor T-cell Therapy in a Patient with High-grade B-cell Lymphoma.Internal medicine (Tokyo, Japan) · 2026Article
- Case Report: Neurolymphomatosis of the sciatic nerve as a presentation of relapsed diffuse large B-cell lymphoma.Frontiers in oncology · 2026Article
- Clinical Spectrum, Diagnostic Work-up, and Outcomes of Neurolymphomatosis in Lymphoid Malignancies: A 10-Patient Case Series.Blood and lymphatic cancer : targets and therapy · 2026Article
- Efficacy of PR2-based immunotherapy in the treatment of diffuse large B-cell lymphoma-associated neurolymphomatosis: A report on two cases.Annals of hematology · 2025Article
- Neurolymphomatosis: The Sinister Face of Lymphoma.Molecular imaging and radionuclide therapy · 2025Article
- Clinical and Electrophysiological Characteristics of 23 French Patients With Neurolymphomatosis.Muscle & nerve · 2025Article
- Primary Neurolymphomatosis: A Literature Review.European journal of neurology · 2025Review
- The natural history of neurolymphomatosis.BJC reports · 2024Article
- Multimodality imaging review of ulnar nerve pathologies.The neuroradiology journal · 2024Article
- Case report: Solitary mass of the sciatic nerve confirmed as a primary extranodal manifestation of diffuse large B-cell lymphoma in a geriatric patient.Frontiers in oncology · 2024Article
- Article
- Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis.International journal of hematology · 2023Article
- COVID-19 associated Bell's Palsy and lumbosacral neurolymphomatosis in a patient with B-cell lymphoma-Case Report.Spinal cord series and cases · 2023Review
- Neurolymphomatosis in Recrudescent Diffuse Large B-cell Lymphoma.Asia Oceania journal of nuclear medicine & biology · 2023Article
- Neurolymphomatosis: an uncommon manifestation of lymphoma - detection and therapeutic monitoring through 18F-fluorodeoxyglucose positron-emission tomography and computed tomography imaging.BMJ case reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo examine the MRI and MATERIALS AND
methodsAll institutional cases of neurolymphomatosis with an MRI or
resultsThere were 27 cases of B-cell neurolymphomatosis in 25 patients (18 M, 7 F; mean age 64.6 ± 10.0 years). Of the total cases, 85% (23/27) were biopsy-proven. Most were diagnosed after disease progression or recurrence (20/27, 74%), and presented with isolated nerve involvement (18/27, 67%). Bone marrow biopsy (17/19, 89%) and CSF cytology (16/23, 70%) were usually negative. On
conclusionsB-cell neurolymphomatosis most commonly manifests as T2-weighted hyperintense, enhancing linear or fusiform neural enlargement associated with muscular denervation on MRI, with intense FDG activity on PET/CT. It is most often an isolated site of disease, presenting after progression or recurrence. A familiarity with the imaging appearance of neurolymphomatosis can help refine the differential diagnosis, direct biopsy, and aid in accurate diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.